Abstract
suitable to be used as a screening test. Hysterosalpingogram (HSG) has been advocated as first-line investigation historically. With advances
in diagnostics, more tests are available, such as hysterosalpingo contrast sonography (HyCoSy) and Chlamydia antibody titre (CAT) are available.
The CAT test is much cheaper, less invasive and can be performed at any time during the cycle. The CAT test can also be used as a
means of identifying which patients need further evaluation. HyCoSy has same diagnostic accuracy as HSG, without exposing women to
radiation. We argue that HSG is out of date and has no place in a modern infertility evaluation. We also suggest a pathway (based on
history, clinical and ultrasound evaluation) for investigations to screen for and diagnose tubal pathology.
Original language | English |
---|---|
Pages (from-to) | 967-971 |
Number of pages | 5 |
Journal | Human Reproduction |
Volume | 26 |
Issue number | 5 |
Early online date | 26 Feb 2011 |
DOIs | |
Publication status | Published - May 2011 |
Fingerprint
Keywords
- tubal patency test
- hysterosalpingogram
- hysterosalpingo contrast sonography
- chlamydia antibody titre
- infertility
Cite this
Should a hysterosalpingogram be a first-line investigation to diagnose female tubal subfertitlity in the modern subfertility workup? / Lim, Chou Pay; Hasafa, Zaid; Bhattacharya, Siladitya; Maheshwari, Abha.
In: Human Reproduction, Vol. 26, No. 5, 05.2011, p. 967-971.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Should a hysterosalpingogram be a first-line investigation to diagnose female tubal subfertitlity in the modern subfertility workup?
AU - Lim, Chou Pay
AU - Hasafa, Zaid
AU - Bhattacharya, Siladitya
AU - Maheshwari, Abha
PY - 2011/5
Y1 - 2011/5
N2 - Tubal assessment is an integral part of female fertility evaluation. While diagnostic laparoscopy is gold standard, it is not suitable to be used as a screening test. Hysterosalpingogram (HSG) has been advocated as first-line investigation historically. With advances in diagnostics, more tests are available, such as hysterosalpingo contrast sonography (HyCoSy) and Chlamydia antibody titre (CAT) are available. The CAT test is much cheaper, less invasive and can be performed at any time during the cycle. The CAT test can also be used as a means of identifying which patients need further evaluation. HyCoSy has same diagnostic accuracy as HSG, without exposing women to radiation. We argue that HSG is out of date and has no place in a modern infertility evaluation. We also suggest a pathway (based on history, clinical and ultrasound evaluation) for investigations to screen for and diagnose tubal pathology.
AB - Tubal assessment is an integral part of female fertility evaluation. While diagnostic laparoscopy is gold standard, it is not suitable to be used as a screening test. Hysterosalpingogram (HSG) has been advocated as first-line investigation historically. With advances in diagnostics, more tests are available, such as hysterosalpingo contrast sonography (HyCoSy) and Chlamydia antibody titre (CAT) are available. The CAT test is much cheaper, less invasive and can be performed at any time during the cycle. The CAT test can also be used as a means of identifying which patients need further evaluation. HyCoSy has same diagnostic accuracy as HSG, without exposing women to radiation. We argue that HSG is out of date and has no place in a modern infertility evaluation. We also suggest a pathway (based on history, clinical and ultrasound evaluation) for investigations to screen for and diagnose tubal pathology.
KW - tubal patency test
KW - hysterosalpingogram
KW - hysterosalpingo contrast sonography
KW - chlamydia antibody titre
KW - infertility
U2 - 10.1093/humrep/der046
DO - 10.1093/humrep/der046
M3 - Article
VL - 26
SP - 967
EP - 971
JO - Human Reproduction
JF - Human Reproduction
SN - 0268-1161
IS - 5
ER -